# Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea

> **NCT01955252** · PHASE3 · COMPLETED · sponsor: **Lihir Medical Centre** · enrollment: 16000 (actual)

## Conditions studied

- Yaws

## Interventions

- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT01955252
- **Lead sponsor:** Lihir Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 16000 (ACTUAL)
- **Last updated:** 2017-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01955252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01955252, "Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01955252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*